Securian Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.04M | Sell |
|
|||||
|
2025
Q2 | $949K | Hold |
|
|||||
|
2025
Q1 | $835K | Sell |
|
|||||
|
2024
Q4 | $1.04M | Sell |
|
|||||
|
2024
Q3 | $905K | Sell |
|
|||||
|
2024
Q2 | $1.1M | Sell |
|
|||||
|
2024
Q1 | $1.12M | Sell |
|
|||||
|
2023
Q4 | $1.09M | Hold |
|
|||||
|
2023
Q3 | $930K | Sell |
|
|||||
|
2023
Q2 | $820K | Sell |
|
|||||
|
2023
Q1 | $894K | Hold |
|
|||||
|
2022
Q4 | $1.06M | Buy |
|
|||||
|
2022
Q3 | $925K | Hold |
|
|||||
|
2022
Q2 | $849K | Buy |
|
|||||
|
2022
Q1 | $796K | Hold |
|
|||||
|
2021
Q4 | $723K | Hold |
|
|||||
|
2021
Q3 | $814K | Sell |
|
|||||
|
2021
Q2 | $846K | Sell |
|
|||||
|
2021
Q1 | $862K | Buy |
|